DaVita IncDVA
Price$176.35Intrinsic value$448.93155% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $448.93median of 5 methods · middle span $136-$966based on filings through 30 Jun 2026
Market Price $176.35Price as of 1 Oct 2026
Margin of Safety +154.6%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 24.8% (near-term consensus, capped) · years 2–5: 22.1%/yr (balance of the path).22.6% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 619.9%Yr 717.6%Yr 815.4%Yr 913.2%Yr 1011.0%
22.1% → 11.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1110.2%Yr 129.4%Yr 138.6%Yr 147.8%Yr 157.0%Yr 166.2%Yr 175.4%Yr 184.6%Yr 193.8%Yr 203.0%
11.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)11.0%
Discount rate (cost of equity) 9.0%
Volatility vs market (adjusted beta)0.91

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetDaVita IncDVAHealth Care
Valuation
P/E14.5×
P/S0.8×
P/B—
EV / Revenue1.6×
EV / EBITDA9.3×
Profitability
Gross margin—
Operating margin15.0%
Net margin6.1%
FCF margin11.5%
Returns
ROE—
ROA4.8%
ROIC9.0%
Growth
Revenue growth (YoY)9.3%
5-yr fwd EPS growth22.6%
Financial strength
Debt / Equity—
Current ratio1.47×
Altman Z-Score1.7
Interest coverage14.66×
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.